119th Congress · introduced in the House · Mar 25, 2025
Women and Lung Cancer Research and Preventive Services Act of 2025
Official title from Congress.gov
Latest action (Apr 22, 2026): Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Reported to House (Nov 18, 2025)
Women and Lung Cancer Research and Preventive Services Act of 2025
This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations.
The review must
• report on the status of existing research and current knowledge gaps;
• identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and
• provide recommendations for a national lung cancer screening strategy and public education campaign.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)
DEBATE - The House proceeded with forty minutes of debate on H.R. 2319.
Considered under suspension of the rules. (consideration: CR H3020-3021)
Mrs. Harshbarger moved to suspend the rules and pass the bill.
Placed on the Union Calendar, Calendar No. 332.
Reported by the Committee on Energy and Commerce. H. Rept. 119-382.
Reported by the Committee on Energy and Commerce. H. Rept. 119-382.
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
Cancer · Cardiovascular and respiratory health · Government studies and investigations · Health care coverage and access · Health promotion and preventive care · Medical research · Medical tests and diagnostic methods · Women's health
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
41 citations; showing the 25 most recently posted.
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS · lobbying firm or registrant: MASON CONSULTING, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$24,000
Paid to lobbying firm
…5, Innovations in Pediatric Drugs Act S. 836/H.R. 6291, Children and Teens Online Privacy Protection Act (COPPA 2.0) S. 891, Bipartisan Health Care Act S. 1157/H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1482/H.R. 4407, National Nursing Workforce Center Act of 2025 S. 1599/H.R. 6394, Midwive…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SIEMENS MEDICAL SOLUTIONS USA, INC · lobbying firm or registrant: SIEMENS MEDICAL SOLUTIONS USA, INC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$510,000
Spent on own lobbying
H.R. 2319 / S. 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN LUNG ASSOCIATION · lobbying firm or registrant: AMERICAN LUNG ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$70,000
Spent on own lobbying
…nd Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4440, Clinical Trial Modernization Act; S. 5428, Stop the Wait Act of 2026; H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025; S. 1157 Women and Lung Cancer Research and Preventive Services Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ASSOCIATION OF NURSE PRACTITIONERS · lobbying firm or registrant: AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$390,000
Spent on own lobbying
…S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preser…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DAIICHI SANKYO INC · lobbying firm or registrant: DAIICHI SANKYO, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$370,000
Spent on own lobbying
Discussions regarding H.R.946, the ORPHAN Cures Act Discussions related to H.R.2319, the Women and Lung Cancer Research and Preventative Services Act Discussions regarding H.R.4299,the Protecting Patient Access to Cancer and Complex Therapies…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · lobbying firm or registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$1,790,000
Spent on own lobbying
…ost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate th…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. · lobbying firm or registrant: HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Medical/Disease Research/Clinical Labs
$60,000
Spent on own lobbying
HR 2319/ - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer. H.R. 2717/S. 1320…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS · lobbying firm or registrant: MASON CONSULTING, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 22, 2026 · issue area: Health Issues
$24,000
Paid to lobbying firm
…5, Innovations in Pediatric Drugs Act S. 836/H.R. 6291, Children and Teens Online Privacy Protection Act (COPPA 2.0) S. 891, Bipartisan Health Care Act S. 1157/H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1885, Stop the Scroll Act S. 1482, National Nursing Workforce Center Act of 2025 S. 1599…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ASSOCIATION OF NURSE PRACTITIONERS · lobbying firm or registrant: AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$400,000
Spent on own lobbying
…S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preser…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SOCIETY OF THORACIC SURGEONS · lobbying firm or registrant: THE SOCIETY OF THORACIC SURGEONS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$182,593
Spent on own lobbying
…ning units, grants of up to $2 million would help providers acquire vehicles, imaging equipment, and essential software to reach more patients where they live. H.R. 2319/ S.1157- Women in Lung Cancer Research; would provide additional funding for prevention and treatment of lung cancer in women, particularly non-smokers. NIH Fu…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. · lobbying firm or registrant: HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$60,000
Spent on own lobbying
HR 2319/ - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer. H.R. 2717/S. 1320…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · lobbying firm or registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$1,240,000
Spent on own lobbying
…ost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate th…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DAIICHI SANKYO INC · lobbying firm or registrant: DAIICHI SANKYO, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 19, 2026 · issue area: Health Issues
$380,000
Spent on own lobbying
Discussions regarding H.R.946, the ORPHAN Cures Act Discussions related to H.R.2319, the Women and Lung Cancer Research and Preventative Services Act Discussions related to the Protecting Patient Access to Cancer and Complex Therapies Act rein…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS · lobbying firm or registrant: MASON CONSULTING, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 24, 2026 · issue area: Health Issues
$24,000
Paid to lobbying firm
…5, Innovations in Pediatric Drugs Act S. 836/H.R. 6291, Children and Teens Online Privacy Protection Act (COPPA 2.0) S. 891, Bipartisan Health Care Act S. 1157/H.R. 2319, Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1885, Stop the Scroll Act S. 1261, Creating Opportunities Now for Necessary and Effectiv…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. · lobbying firm or registrant: HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 21, 2026 · issue area: Medical/Disease Research/Clinical Labs
$60,000
Spent on own lobbying
HR 2319/ - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer. H.R. 2717/S. 1320…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DAIICHI SANKYO INC · lobbying firm or registrant: DAIICHI SANKYO, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Health Issues
$130,000
Spent on own lobbying
Discussions regarding H.R.946, the ORPHAN Cures Act Discussions related to H.R.2319, the Women and Lung Cancer Research and Preventative Services Act Discussions related to the Protecting Patient Access to Cancer and Complex Therapies Act rein…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SIEMENS MEDICAL SOLUTIONS USA, INC · lobbying firm or registrant: SIEMENS MEDICAL SOLUTIONS USA, INC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Medicare/Medicaid
$700,000
Spent on own lobbying
…S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ASSOCIATION OF NURSE PRACTITIONERS · lobbying firm or registrant: AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Health Issues
$400,000
Spent on own lobbying
…S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preser…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · lobbying firm or registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Health Issues
$2,300,000
Spent on own lobbying
…ost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate th…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SOCIETY OF THORACIC SURGEONS · lobbying firm or registrant: THE SOCIETY OF THORACIC SURGEONS
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$333,610
Spent on own lobbying
…ning units, grants of up to $2 million would help providers acquire vehicles, imaging equipment, and essential software to reach more patients where they live. H.R. 2319/ S.1157- Women in Lung Cancer Research; would provide additional funding for prevention and treatment of lung cancer in women, particularly non-smokers. H.R.11…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DAIICHI SANKYO INC · lobbying firm or registrant: DAIICHI SANKYO, INC.
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Health Issues
$90,000
Spent on own lobbying
Discussions regarding H.R.946, the ORPHAN Cures Act Discussions related to H.R.2319, the Women and Lung Cancer Research and Preventative Services Act Discussions related to the Protecting Patient Access to Cancer and Complex Therapies Act rein…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SIEMENS MEDICAL SOLUTIONS USA, INC · lobbying firm or registrant: SIEMENS MEDICAL SOLUTIONS USA, INC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Medicare/Medicaid
$720,000
Spent on own lobbying
…/ S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025;H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · lobbying firm or registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Health Issues
$2,380,000
Spent on own lobbying
…ost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate th…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ASSOCIATION OF NURSE PRACTITIONERS · lobbying firm or registrant: AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Health Issues
$550,000
Spent on own lobbying
…S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preser…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SOCIETY OF THORACIC SURGEONS · lobbying firm or registrant: THE SOCIETY OF THORACIC SURGEONS
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$183,560
Spent on own lobbying
…its, grants of up to $2 million would help providers acquire vehicles, imaging equipment, and essential software to reach more patients where they live. S.1157/H.R. 2319- Women in Lung Cancer Research; Would provide additional funding for prevention and treatment of lung cancer in women, particularly non-smokers. NIH Funding: C…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing